Literature DB >> 18093797

An updated version of the Weigl discriminates adults with dementia from those with mild impairment and healthy controls.

Leigh J Beglinger1, Frederick W Unverzagt, Xabier Beristain, David Kareken.   

Abstract

Dementia screening batteries often fall short on measures of executive functioning. The Weigl Color Form Sorting Test (WCFST) is a candidate for inclusion in such batteries, but can be insensitive to mild disturbance. The WCFST consists of 12 colored geometric shapes and requires the patient to sort the pieces by color or form, and then shift to the other sorting principle unassisted. We created a modified version of the WCFST (the Weigl-R) with increased conceptual complexity by adding two stimulus dimensions (texture and central shapes). The range of scores was also increased by adding the extent of examiner assistance required to achieve a correct sort, ability to verbalize conceptual strategy, and number of perseverations. We administered the Weigl-R to a group of 30 patients with mixed dementias, 34 adults with cognitive impairment without dementia, and 21 healthy controls. The new measure discriminated well between healthy controls and older adults with either cognitive impairment without dementia, or dementia. The Weigl-R may be a useful adjunct to brief dementia batteries but requires further validation.

Entities:  

Mesh:

Year:  2008        PMID: 18093797      PMCID: PMC2760247          DOI: 10.1016/j.acn.2007.11.002

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  28 in total

1.  Wisconsin card sorting test: a new global score, with Italian norms, and its relationship with the Weigl sorting test.

Authors:  M Laiacona; M G Inzaghi; A De Tanti; E Capitani
Journal:  Neurol Sci       Date:  2000-10       Impact factor: 3.307

2.  Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery.

Authors:  M F Newman; J L Kirchner; B Phillips-Bute; V Gaver; H Grocott; R H Jones; D B Mark; J G Reves; J A Blumenthal
Journal:  N Engl J Med       Date:  2001-02-08       Impact factor: 91.245

Review 3.  Test review: Delis-Kaplan executive function system.

Authors:  Susan Homack; Donghyung Lee; Cynthia A Riccio
Journal:  J Clin Exp Neuropsychol       Date:  2005-07       Impact factor: 2.475

4.  The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

Authors:  G Blessed; B E Tomlinson; M Roth
Journal:  Br J Psychiatry       Date:  1968-07       Impact factor: 9.319

5.  The Clinical Dementia Rating (CDR): current version and scoring rules.

Authors:  J C Morris
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

6.  Striatal volume loss in HD as measured by MRI and the influence of CAG repeat.

Authors:  H D Rosas; J Goodman; Y I Chen; B G Jenkins; D N Kennedy; N Makris; M Patti; L J Seidman; M F Beal; W J Koroshetz
Journal:  Neurology       Date:  2001-09-25       Impact factor: 9.910

7.  Prevalence and severity of cognitive impairment with and without dementia in an elderly population.

Authors:  J E Graham; K Rockwood; B L Beattie; R Eastwood; S Gauthier; H Tuokko; I McDowell
Journal:  Lancet       Date:  1997-06-21       Impact factor: 79.321

8.  Prevalence of cognitive impairment: data from the Indianapolis Study of Health and Aging.

Authors:  F W Unverzagt; S Gao; O Baiyewu; A O Ogunniyi; O Gureje; A Perkins; C L Emsley; J Dickens; R Evans; B Musick; K S Hall; S L Hui; H C Hendrie
Journal:  Neurology       Date:  2001-11-13       Impact factor: 9.910

9.  Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

Authors:  G C Román; T K Tatemichi; T Erkinjuntti; J L Cummings; J C Masdeu; J H Garcia; L Amaducci; J M Orgogozo; A Brun; A Hofman
Journal:  Neurology       Date:  1993-02       Impact factor: 9.910

10.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease.

Authors:  J C Morris; A Heyman; R C Mohs; J P Hughes; G van Belle; G Fillenbaum; E D Mellits; C Clark
Journal:  Neurology       Date:  1989-09       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.